In most countries, prostate cancer incidence and mortality rates decreased or were stable in the most recent five-year period ...

The immunotherapy, CAN-2409, in combination with radiation therapy, helped 75.2% patients live without any sign of the cancer ...

Published in Nature Communications, a new study led by the University of Minnesota Medical School and Duke University found ...

Eddie Jordan has spoken publicly about a "quite aggressive" bladder and prostate cancer diagnosis he received earlier this ...

A phase 3 prostate cancer trial of Candel’s oncolytic virus has met its primary endpoint, sending the stock up more than 200% ...

Montell Jordan is advocating for prostate cancer awareness and emphasizing the importance of early detection, particularly ...

Former Chicago Cubs player Ryne Sandberg recently took to social media to share a devastating update regarding his health ...

Prostate cancer vaccines, including dendritic and peptide types, offer hope for improved treatments, but face hurdles in ...

Candel Therapeutics' CAN-2409 shows a 14.5% improvement in prostate cancer survival. Discover why CADL stock stays a "Buy" ...

Sky Sports is supporting The BIGGER 180 campaign; in the UK, one man dies from prostate cancer every 45 minutes but finding ...

Candel Therapeutics reports phase 3 trial success for CAN-2409 in prostate cancer, showing improved disease-free survival and ...